Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology.
Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology.
复制标题
DOI：
10.1007/s40122-021-00343-z
复制
发表时间：
2022-03
期刊：
影响因子：
4
通讯作者：
Freeman PR
中科院分区：
文献类型：
--
作者：
Dasgupta N;Brown JR;Nocera M;Lazard A;Slavova S;Freeman PR
Evaluate beliefs and behaviors pertaining to abuse-deterrent opioids (ADFs). Survey in 2019 by invitation to all licensed physicians. Commonwealth of Kentucky. 374 physicians. Descriptive statistics, and hypothesis test that early adopter prescribers would have greater endorsement of opioid risk management. Of all prescribers, 55% believed all opioid analgesics should have ADF requirements (15% were unsure); 74% supported mandating insurance coverage. Only one-third considered whether an opioid was ADF when prescribing, motivated by patient family diversion (94%) and societal supply reduction (88%). About half believed ADFs were equally effective in preventing abuse by intact swallowing, injection, chewing, snorting, smoking routes. Only 4% of OxyContin prescribers chose it primarily because of ADF properties. Instead, the most common reason (33%) was being started by another prescriber. A quarter of physicians chose not to prescribe ADFs because of heroin switching potential. Early adopters strongly believed ADFs were effective in reducing abuse (PR 3.2; 95% CI 1.5, 6.6) compared to mainstream physicians. Early-adopter risk-management practices more often included tools increasing agency and measurement: urine drug screens (PR 2.0; 1.3, 3.1), risk screening (PR 1.3; 0.94, 1.9). While nearly all respondents (96%) felt that opioid abuse was a problem in the community, only 57% believed it was a problem among patients in their practice. Attribution theory revealed an externalization of opioid abuse problems that deflected blame from patients on to family members. The primary motivator for prescribing ADFs was preventing diversion by family members, not patient-level abuse concerns. The online version contains supplementary material available at 10.1007/s40122-021-00343-z.
登录
查看更多内容
影响因子：
2.9
作者：
DENIG, P;HAAIJER-RUSKAMP, FM;VERSLUIS, A
通讯作者：
VERSLUIS, A
影响因子：
5.4
作者：
Brookhart, MA;Wang, PS;Schneeweiss, S
通讯作者：
Schneeweiss, S
影响因子：
2.8
作者：
Dunn AG;Braithwaite J;Gallego B;Day RO;Runciman W;Coiera E
通讯作者：
Coiera E
影响因子：
3.1
作者：
Butler, Stephen F.;Black, Ryan;Katz, Nathaniel
通讯作者：
Katz, Nathaniel
影响因子：
2.9
作者：
Hwang, Catherine S.;Turner, Lydia W.;Alexander, G. Caleb
通讯作者：
Alexander, G. Caleb